Key Ingredients for Effective NMPA (CFDA) CER & Clinical Trial

  • Version
  • Download 3
  • File Size 0.00 KB
  • File Count 1
  • Create Date June 13, 2018
  • Last Updated January 6, 2022

Key Ingredients for Effective NMPA (CFDA) CER & Clinical Trial

CFDA clinical requirements for medical device/IVD have been evolving dynamically in the past few years. It is important for foreign manufacturers to understand the China specific clinical requirements, available clinical routes with CFDA registration, and major clinical related regulatory changes.

This webinar will cover the following aspects:

  • What are the criteria for different clinical routes in China?
  • How much does it cost you to run clinical trials in China?
  • When should you decide which clinical route to take in China?
  • What are the key ingredients for effective clinical trial in China?

Attached Files

File
PzY69BSpcNM